Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 2735 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 4351 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 4445 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 4463 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 4813 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 4847 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 5101 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 5206 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 5327 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 5385 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 5522 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 5720 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 5834 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 5877 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 6020 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 6161 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 6187 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 6200 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 6271 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 6335 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 6348 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 6389 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 6490 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 6644 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 6676 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 6703 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 6819 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 6927 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 6953 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 7150 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 7192 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 7234 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 7302 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 7435 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 7466 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 7559 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 7564 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 7663 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 7724 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 7772 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 7846 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 7891 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 7902 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 8054 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 8498 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 8584 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 8594 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 8694 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 8977 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 9051 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 9051 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 9093 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 9234 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 9464 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 9501 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 9515 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 9798 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 9822 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 9954 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 9966 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 10222 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 10235 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 10268 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 10456 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 10854 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 10936 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 11199 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 11273 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 11314 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 11508 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 11555 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 11601 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 11957 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 12206 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 12418 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 13172 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 13278 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 13505 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 13610 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 13613 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 14501 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 14518 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 14953 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 15227 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 15805 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 16137 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 16370 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 16649 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 16757 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 17424 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 18810 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 19041 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 20508 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 20850 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 21111 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 21524 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 21644 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 22790 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 23490 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | LAURIC ACID (CAS# 143-07-7); (M-H)- | 33011 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |